Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 44 | 2024 | 1197 | 6.420 |
Why?
|
| Mammography | 27 | 2024 | 281 | 5.130 |
Why?
|
| Breast Diseases | 12 | 2023 | 40 | 3.210 |
Why?
|
| Contrast Media | 8 | 2023 | 427 | 2.300 |
Why?
|
| Breast | 10 | 2023 | 183 | 2.090 |
Why?
|
| Magnetic Resonance Imaging | 21 | 2023 | 2176 | 1.660 |
Why?
|
| Image-Guided Biopsy | 5 | 2018 | 43 | 1.320 |
Why?
|
| Societies, Medical | 11 | 2024 | 379 | 1.300 |
Why?
|
| Early Detection of Cancer | 13 | 2024 | 322 | 1.160 |
Why?
|
| Female | 69 | 2025 | 32871 | 1.040 |
Why?
|
| Healthcare Disparities | 3 | 2025 | 359 | 0.970 |
Why?
|
| Precancerous Conditions | 3 | 2021 | 70 | 0.940 |
Why?
|
| Diagnostic Imaging | 5 | 2023 | 264 | 0.920 |
Why?
|
| Humans | 82 | 2025 | 63429 | 0.840 |
Why?
|
| Homosexuality, Female | 1 | 2023 | 21 | 0.820 |
Why?
|
| Radiographic Image Enhancement | 2 | 2020 | 98 | 0.810 |
Why?
|
| Health Services Accessibility | 3 | 2024 | 564 | 0.790 |
Why?
|
| Radiology | 5 | 2021 | 252 | 0.780 |
Why?
|
| Wernicke Encephalopathy | 1 | 2022 | 5 | 0.760 |
Why?
|
| Thiamine Deficiency | 1 | 2022 | 8 | 0.760 |
Why?
|
| Sexual and Gender Minorities | 1 | 2023 | 76 | 0.740 |
Why?
|
| Breast Carcinoma In Situ | 1 | 2021 | 3 | 0.740 |
Why?
|
| Ultrasonography, Mammary | 6 | 2019 | 16 | 0.730 |
Why?
|
| Carcinoma, Lobular | 1 | 2021 | 26 | 0.720 |
Why?
|
| Carcinoma in Situ | 1 | 2021 | 35 | 0.720 |
Why?
|
| Parenchymal Tissue | 1 | 2020 | 5 | 0.700 |
Why?
|
| Practice Management, Medical | 2 | 2018 | 21 | 0.680 |
Why?
|
| Middle Aged | 28 | 2025 | 17598 | 0.670 |
Why?
|
| Cerebral Ventricles | 6 | 2011 | 29 | 0.620 |
Why?
|
| Biopsy | 4 | 2017 | 444 | 0.610 |
Why?
|
| Video Recording | 2 | 2017 | 135 | 0.610 |
Why?
|
| Mass Screening | 7 | 2024 | 690 | 0.570 |
Why?
|
| Lymph Nodes | 2 | 2018 | 226 | 0.560 |
Why?
|
| Workflow | 1 | 2018 | 70 | 0.550 |
Why?
|
| Retrospective Studies | 18 | 2023 | 6658 | 0.550 |
Why?
|
| Incidental Findings | 1 | 2017 | 44 | 0.540 |
Why?
|
| Adult | 27 | 2025 | 16822 | 0.530 |
Why?
|
| Sensitivity and Specificity | 10 | 2023 | 1148 | 0.510 |
Why?
|
| Teaching Materials | 1 | 2016 | 12 | 0.500 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2018 | 65 | 0.500 |
Why?
|
| Education, Medical, Graduate | 4 | 2023 | 351 | 0.500 |
Why?
|
| Aged | 18 | 2025 | 14432 | 0.500 |
Why?
|
| Ultrasonography, Prenatal | 9 | 2011 | 43 | 0.500 |
Why?
|
| Radiology, Interventional | 1 | 2016 | 32 | 0.490 |
Why?
|
| Stereotaxic Techniques | 2 | 2014 | 29 | 0.480 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 105 | 0.460 |
Why?
|
| Fetal Diseases | 4 | 2011 | 21 | 0.450 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 297 | 0.450 |
Why?
|
| Evidence-Based Medicine | 8 | 2024 | 462 | 0.440 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 174 | 0.430 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 289 | 0.410 |
Why?
|
| Diagnosis, Differential | 8 | 2019 | 978 | 0.400 |
Why?
|
| Biopsy, Large-Core Needle | 4 | 2021 | 20 | 0.400 |
Why?
|
| Prenatal Diagnosis | 4 | 2011 | 39 | 0.400 |
Why?
|
| Patient Care Team | 1 | 2015 | 338 | 0.390 |
Why?
|
| Liver | 1 | 2017 | 855 | 0.390 |
Why?
|
| Needles | 2 | 2018 | 67 | 0.390 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 5456 | 0.390 |
Why?
|
| Quality of Health Care | 2 | 2015 | 519 | 0.370 |
Why?
|
| Epithelial Cells | 1 | 2014 | 389 | 0.370 |
Why?
|
| Gynecomastia | 2 | 2018 | 11 | 0.370 |
Why?
|
| Breast Implants | 2 | 2023 | 13 | 0.360 |
Why?
|
| Fellowships and Scholarships | 3 | 2023 | 108 | 0.350 |
Why?
|
| United States | 16 | 2025 | 7841 | 0.320 |
Why?
|
| Calcinosis | 3 | 2019 | 85 | 0.310 |
Why?
|
| Breast Density | 4 | 2022 | 17 | 0.300 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2019 | 26 | 0.290 |
Why?
|
| Radiologists | 2 | 2019 | 89 | 0.280 |
Why?
|
| Cultural Competency | 2 | 2024 | 52 | 0.260 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2019 | 179 | 0.250 |
Why?
|
| Pregnancy, Ectopic | 2 | 2008 | 10 | 0.240 |
Why?
|
| Vascular Malformations | 1 | 2025 | 22 | 0.230 |
Why?
|
| Central Nervous System | 2 | 2005 | 197 | 0.230 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2025 | 44 | 0.230 |
Why?
|
| Decidua | 1 | 2004 | 3 | 0.230 |
Why?
|
| Patient Preference | 3 | 2025 | 84 | 0.220 |
Why?
|
| Translating | 1 | 2024 | 18 | 0.220 |
Why?
|
| Postoperative Complications | 3 | 2020 | 1308 | 0.220 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2024 | 20 | 0.220 |
Why?
|
| Hyperplasia | 2 | 2021 | 88 | 0.210 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2025 | 153 | 0.210 |
Why?
|
| Communication Barriers | 1 | 2024 | 67 | 0.210 |
Why?
|
| Renal Dialysis | 1 | 2025 | 198 | 0.210 |
Why?
|
| Culture | 1 | 2024 | 78 | 0.210 |
Why?
|
| Ultrasonography, Doppler | 1 | 2003 | 27 | 0.210 |
Why?
|
| Pregnancy | 12 | 2018 | 2336 | 0.200 |
Why?
|
| Image Enhancement | 2 | 2015 | 192 | 0.200 |
Why?
|
| Gender Identity | 1 | 2023 | 67 | 0.200 |
Why?
|
| Patient Navigation | 1 | 2023 | 35 | 0.200 |
Why?
|
| Surveys and Questionnaires | 4 | 2025 | 2679 | 0.200 |
Why?
|
| Dehydration | 1 | 2022 | 17 | 0.190 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2021 | 3 | 0.190 |
Why?
|
| Thiamine | 1 | 2022 | 21 | 0.190 |
Why?
|
| Research | 1 | 2023 | 193 | 0.190 |
Why?
|
| Transaminases | 1 | 2022 | 14 | 0.190 |
Why?
|
| Clinical Competence | 4 | 2018 | 727 | 0.190 |
Why?
|
| Pericarditis | 1 | 2021 | 10 | 0.190 |
Why?
|
| Lower Urinary Tract Symptoms | 1 | 2021 | 8 | 0.190 |
Why?
|
| Sexual Behavior | 1 | 2023 | 194 | 0.190 |
Why?
|
| Prostatic Hyperplasia | 1 | 2021 | 20 | 0.180 |
Why?
|
| Time Factors | 3 | 2019 | 3767 | 0.180 |
Why?
|
| Reproducibility of Results | 6 | 2016 | 1652 | 0.180 |
Why?
|
| Observer Variation | 2 | 2020 | 214 | 0.180 |
Why?
|
| Needs Assessment | 1 | 2023 | 198 | 0.180 |
Why?
|
| Age Factors | 3 | 2020 | 1559 | 0.180 |
Why?
|
| Educational Status | 1 | 2023 | 275 | 0.180 |
Why?
|
| Serine | 1 | 2022 | 91 | 0.180 |
Why?
|
| Gestational Age | 6 | 2011 | 189 | 0.180 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 178 | 0.170 |
Why?
|
| Transgender Persons | 1 | 2021 | 69 | 0.170 |
Why?
|
| Ischemia | 1 | 2002 | 205 | 0.170 |
Why?
|
| Quality of Life | 2 | 2025 | 1228 | 0.170 |
Why?
|
| Predictive Value of Tests | 3 | 2022 | 1093 | 0.170 |
Why?
|
| Thrombectomy | 1 | 2002 | 234 | 0.160 |
Why?
|
| Mammaplasty | 1 | 2020 | 48 | 0.160 |
Why?
|
| Thrombosis | 1 | 2002 | 199 | 0.160 |
Why?
|
| Iohexol | 1 | 2019 | 18 | 0.160 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2019 | 46 | 0.160 |
Why?
|
| Cryptococcosis | 1 | 2020 | 79 | 0.160 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 87 | 0.150 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 319 | 0.150 |
Why?
|
| Mastodynia | 1 | 2018 | 3 | 0.150 |
Why?
|
| Glucose | 1 | 2022 | 467 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 345 | 0.150 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 536 | 0.150 |
Why?
|
| Papilloma | 1 | 2018 | 12 | 0.150 |
Why?
|
| Prospective Studies | 5 | 2025 | 3290 | 0.150 |
Why?
|
| Forecasting | 1 | 2019 | 232 | 0.150 |
Why?
|
| Embolization, Therapeutic | 1 | 2021 | 320 | 0.140 |
Why?
|
| Male | 10 | 2025 | 29893 | 0.140 |
Why?
|
| Liver Transplantation | 1 | 2020 | 216 | 0.140 |
Why?
|
| Educational Measurement | 2 | 2017 | 218 | 0.140 |
Why?
|
| Menopause | 1 | 2020 | 258 | 0.140 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 88 | 0.140 |
Why?
|
| Job Satisfaction | 1 | 2018 | 137 | 0.140 |
Why?
|
| Efficiency, Organizational | 1 | 2018 | 96 | 0.140 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 317 | 0.130 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 68 | 0.130 |
Why?
|
| Burnout, Professional | 1 | 2018 | 135 | 0.130 |
Why?
|
| Carcinoma | 1 | 2017 | 123 | 0.130 |
Why?
|
| Osteoarthritis, Knee | 1 | 2021 | 385 | 0.130 |
Why?
|
| Computers, Handheld | 1 | 2016 | 38 | 0.120 |
Why?
|
| Ultrasonography | 3 | 2010 | 484 | 0.120 |
Why?
|
| Patient Safety | 1 | 2018 | 243 | 0.120 |
Why?
|
| Internship and Residency | 3 | 2017 | 805 | 0.120 |
Why?
|
| Mucocele | 1 | 2015 | 2 | 0.120 |
Why?
|
| Patient Care | 1 | 2015 | 80 | 0.120 |
Why?
|
| Central Nervous System Diseases | 2 | 2008 | 57 | 0.120 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2015 | 15 | 0.110 |
Why?
|
| Vacuum | 1 | 2014 | 7 | 0.110 |
Why?
|
| Attitude to Health | 1 | 2016 | 289 | 0.110 |
Why?
|
| Transsexualism | 1 | 2014 | 14 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 663 | 0.110 |
Why?
|
| Health Care Reform | 1 | 2015 | 87 | 0.110 |
Why?
|
| Health Promotion | 1 | 2018 | 497 | 0.110 |
Why?
|
| Culturally Competent Care | 2 | 2024 | 17 | 0.110 |
Why?
|
| Patient Positioning | 1 | 2014 | 49 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 712 | 0.100 |
Why?
|
| Curriculum | 4 | 2023 | 598 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 771 | 0.100 |
Why?
|
| Mammary Glands, Human | 1 | 2012 | 56 | 0.090 |
Why?
|
| Fibroadenoma | 1 | 2011 | 3 | 0.090 |
Why?
|
| Pregnancy Outcome | 3 | 2011 | 194 | 0.090 |
Why?
|
| Neoplasms | 1 | 2022 | 1362 | 0.090 |
Why?
|
| Prevalence | 2 | 2015 | 1380 | 0.090 |
Why?
|
| Septum Pellucidum | 1 | 2011 | 4 | 0.090 |
Why?
|
| Pain | 2 | 2025 | 406 | 0.080 |
Why?
|
| Adolescent | 4 | 2025 | 6250 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 1644 | 0.080 |
Why?
|
| Echoencephalography | 1 | 2009 | 13 | 0.080 |
Why?
|
| Algorithms | 1 | 2015 | 1001 | 0.080 |
Why?
|
| Receptors, Estrogen | 2 | 2023 | 128 | 0.080 |
Why?
|
| Intracranial Hemorrhages | 1 | 2009 | 67 | 0.080 |
Why?
|
| Adnexal Diseases | 1 | 2008 | 8 | 0.070 |
Why?
|
| Mastectomy | 2 | 2020 | 58 | 0.070 |
Why?
|
| Boston | 2 | 2020 | 252 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2021 | 5680 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2024 | 2079 | 0.060 |
Why?
|
| Young Adult | 3 | 2025 | 4692 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 311 | 0.050 |
Why?
|
| Silicones | 1 | 2023 | 14 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2025 | 345 | 0.050 |
Why?
|
| Breast Implantation | 1 | 2003 | 6 | 0.050 |
Why?
|
| Area Under Curve | 1 | 2023 | 146 | 0.050 |
Why?
|
| Thorax | 1 | 2003 | 34 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2003 | 78 | 0.050 |
Why?
|
| Physical Examination | 1 | 2023 | 112 | 0.050 |
Why?
|
| Fetus | 1 | 2003 | 98 | 0.050 |
Why?
|
| Organoids | 1 | 2023 | 43 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2011 | 609 | 0.050 |
Why?
|
| Documentation | 1 | 2023 | 128 | 0.050 |
Why?
|
| Rheology | 1 | 2002 | 74 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 157 | 0.050 |
Why?
|
| Leg | 1 | 2002 | 87 | 0.050 |
Why?
|
| Colchicine | 1 | 2021 | 28 | 0.050 |
Why?
|
| Injections, Intra-Articular | 1 | 2021 | 51 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2023 | 389 | 0.040 |
Why?
|
| Prostate | 1 | 2021 | 90 | 0.040 |
Why?
|
| Computer-Assisted Instruction | 1 | 2002 | 80 | 0.040 |
Why?
|
| Counseling | 1 | 2003 | 362 | 0.040 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2021 | 129 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2002 | 214 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 124 | 0.040 |
Why?
|
| Knee Joint | 1 | 2021 | 298 | 0.040 |
Why?
|
| Cryptococcus neoformans | 1 | 2020 | 148 | 0.040 |
Why?
|
| Breast Neoplasms, Male | 1 | 2018 | 14 | 0.040 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 196 | 0.040 |
Why?
|
| Communication | 1 | 2023 | 571 | 0.040 |
Why?
|
| Lactation | 1 | 2018 | 69 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2019 | 100 | 0.040 |
Why?
|
| Infant | 1 | 2023 | 1650 | 0.040 |
Why?
|
| Physicians, Primary Care | 1 | 2019 | 78 | 0.040 |
Why?
|
| Organizational Culture | 1 | 2018 | 110 | 0.030 |
Why?
|
| Leadership | 1 | 2018 | 206 | 0.030 |
Why?
|
| Benchmarking | 1 | 2017 | 137 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2022 | 690 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 1008 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 762 | 0.030 |
Why?
|
| Organizational Objectives | 1 | 2015 | 59 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2015 | 93 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2015 | 147 | 0.030 |
Why?
|
| Massachusetts | 1 | 2019 | 2076 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 215 | 0.020 |
Why?
|
| Radiography | 1 | 2011 | 550 | 0.020 |
Why?
|
| Technology, Radiologic | 1 | 2008 | 9 | 0.020 |
Why?
|
| Professional Practice | 1 | 2008 | 24 | 0.020 |
Why?
|
| Genital Neoplasms, Female | 1 | 2008 | 18 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2008 | 103 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 1277 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 5353 | 0.010 |
Why?
|
| Reference Standards | 1 | 2002 | 73 | 0.010 |
Why?
|
| Endosonography | 1 | 2002 | 26 | 0.010 |
Why?
|
| Abdomen | 1 | 2002 | 91 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 418 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2002 | 125 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2002 | 233 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2002 | 477 | 0.010 |
Why?
|